Related Experiment Video

Updated: Apr 15, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

740

Targeting metabolic disturbance in the diabetic heart

Jesús Fuentes-Antrás, Belén Picatoste, Elisa Ramírez

    Cardiovascular Diabetology
    |April 10, 2015
    PubMed

    Insights

    Diabetic cardiomyopathy, a heart dysfunction in diabetes, worsens outcomes. New research focuses on heart-specific metabolic targets for effective prevention and treatment beyond systemic control.

    Area of Science:

    • Cardiology
    • Metabolic Disorders
    • Diabetology

    Background:

    • Diabetic cardiomyopathy is ventricular dysfunction caused by altered cardiac energy metabolism in diabetic patients.
    • It contributes to increased heart failure risk and poorer outcomes after myocardial ischemia in diabetics.
    • Current tertiary prevention strategies for cardiovascular disease in diabetes are insufficient.

    Purpose of the Study:

    • To review progress in conventional therapies for diabetic cardiomyopathy.
    • To highlight the need for heart-specific metabolic targets in managing diabetic cardiomyopathy.
    • To explore novel therapeutic strategies for next-generation diabetic care.

    Main Methods:

    • Review of experimental and translational research on diabetic cardiomyopathy.
    • Analysis of conventional therapies and their limitations.
    • Identification and discussion of prospective metabolic targets for cardiac health in diabetes.

    Main Results:

    • Conventional therapies have limitations in addressing the metabolic derangements of diabetic cardiomyopathy.
    • Emerging research provides deeper insights into the metabolic etiology of the condition.
    • Numerous heart-specific targets show promise for future interventions.

    Conclusions:

    • Effective management of diabetic cardiomyopathy requires targeting cardiac metabolic derangements.
    • A shift towards heart-specific metabolic interventions is crucial for next-generation diabetic care.
    • Prospective metabolic targets may avert myocardial vulnerability and functional decline in diabetic patients.

    More Related Videos

    Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

    Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

    Published on: November 29, 2024

    1.7K
    Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

    Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

    Published on: September 18, 2017

    10.7K

    Related Concept Videos

    Heart Failure Drugs: Diuretics01:22

    Heart Failure Drugs: Diuretics

    Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
    1.2K
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    1.5K
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    803
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    571
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
    4.6K
    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    2.0K